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Abstract 
 
The aim of this systematic review is to summarise the results of cohort studies that examined 
the incidence of SCD in marathons and to assess the quality of the methods used. A search of 
the PROSPERO international database revealed no prospective or published systematic 
reviews investigating SCD in marathons. The review was conducted using studies that 
reported and characterised the incidence of SCD in people participating in marathons. Studies 
were identified via electronic database searches (Medline, CINAHL, SPORTDiscus and 
Google Scholar) from January 1, 1966 to October 1, 2014 and through manual literature 
searches. 7 studies met the inclusion criteria and were included in this review. 6 of the studies 
were conducted in the USA and 1 in the UK. These studies covered a 34-year period 
involving between 215,413 and 3,949,000 runners. The SCD of between 4 and 28 people are 
recorded in the papers and the reported estimates of the incidence of SCD in marathons 
ranged widely from 0.6 to 1.9 per 100,000 runners. The proportion of those suffering SCD 
who were male ranged from 57.1% to 100% and the mean age reported in the papers, ranged 
from 37 to 48. This review raises 4 methodological concerns over i) collating reports of SCD 
in marathons; ii) time of death in relation to the marathon; iii) the use of registrants rather 
than runners in the estimates of sample size and iv) limited detail on runners exercise history. 
These four concerns all threaten the reliability and interpretation of any estimate of SCD 
incidence rates in marathons. This review recommends that the methods used to collect data 
on SCD in marathons be improved and that a central reporting system be established.  
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Introduction 
 
The aim of this systematic review is to summarise the results of cohort studies that examined 
the incidence of sudden cardiac death (SCD) in marathons and to assess the quality of the 
methods used. A search of the PROSPERO international database revealed no prospective or 
published systematic reviews investigating SCD in marathons. 
 
The health benefits of physical activity are well documented. [1] It has been established that 
regular physical activity and exercise have powerful prophylactic effects in the primary and 
secondary prevention of a number of chronic diseases.[2]  
 
Participation in long-distance running races, especially marathons, has increased since the 
inception of the London Marathon. The inaugural event in 1981 registered <7000 participants 
whereas the race in 2014 recorded 35,798 finishers.[3] The increase in participation has, in 
part, been attributed to a greater public awareness of the health benefits of regular 
exercise.[4] Marathons are big and important events for race organisers, charities, and 
sponsors alike. A study commissioned by the New York Road Runners Club found the 2010 
New York City Marathon was worth $340 million.[5] 
 
Medical and health-care professionals recommend exercise, including running, as a health -
enhancing physical activity. Tragically, for a very small number of marathon runners the 
outcome is SCD. Some have argued that the publicity surrounding these rare events reduces 
the public’s enthusiasm for aerobic exercise.[6,7] A death during a marathon is particularly 
tragic because “the risk is voluntary, the outcome is catastrophic and the individual may 
otherwise have lived a long life” [6, p. 1]. 
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Methods 
 
Carney and Geddes [8] define systematic reviews as a “syntheses of primary research studies 
that use (and describe) specific, explicit and therefore reproducible methodological strategies 
to identify, assemble, critically appraise and synthesise as relevant issues on a specific topic”. 
Informed by the approach of the Cochrane Library, [9] this systematic review was conducted 
to identify, appraise, and synthesize all the empirical evidence to date on SCD in marathons, 
in accordance with prespecified eligibility criteria. By doing so this systematic review adds 
new insights into the quality of the methodologies used in the selected studies and combines 
the findings from the selected studies to present amalgamated results. 
 
This review was conducted in accordance with the Preferred Reporting Items for Systematic 
Reviews and Meta-analyses (PRISMA) Guidelines [10] and prepared to the standards 
established by the International Prospective Register of Systematic Reviews (PROSPERO). 
 
Search strategy 
A systematic, computerized search of the databases Medline, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), and SPORTDiscus was performed to identify 
potentially relevant studies, from inception (1966) until 1October 2014. The database search 
used combinations of “thesaurus terms” and free text words. Synonym lists were created on 
the themes of marathon and death. The following combinations of keywords were used: 
(marathon OR run* OR long distance run*) AND (sudden cardiac death OR sudden death OR 
cardiac death OR cardiac mortality OR cardiac arrest). The searches in Medline, CINAHL, 
and SPORTDiscus were restricted to peer-reviewed articles published in English. Google 
Scholar was also searched in an attempt to identify additional, relevant research using the 
following search terms: allintitle “marathon” OR “run” AND “sudden cardiac death” OR 
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“sudden death” OR “cardiac mortality” OR “cardiac arrest”. The results of these searches 
were combined and duplicates were removed. 
 
Study selection 
All search results were first screened on title, abstract, and keywords. Articles were 
considered relevant, as decided independently by two reviewers if the study met the 
following selection criteria: (1 ) participants were marathon runners; (2 ) an association with 
cardiac death; and (3 ) if the study examined data from original research. Disagreements 
between the two authors regarding the study’s eligibility were resolved by discussion until 
consensus was reached, or when necessary, a third author had the casting vote. Articles 
whose abstracts were imprecise with regard to selection criteria were considered for full text 
analysis.  
 
The reference lists of the articles included following fulltext analysis were screened. This was 
performed to ensure that no relevant studies were missed, which is of particular importance 
due to the paucity of published studies in this area. 
 
Assessment of methodological quality 
The methodological quality of the studies was independently appraised by two reviewers 
using the Critical Appraisal Skills Programme (CASP) Cohort Study checklist.[11] Of the 12 
main criteria outlined in the CASP Cohort Study checklist, criteria 7, 8, and 12 were omitted 
due to the qualitative nature of the questions while criteria 6 was not applicable and therefore 
exempt due to the nature of the studies included in this review. As a result, these criteria were 
not included in AQ1 the scoring system outlined in Table 1. The other 8 criteria for the 
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assessment of methodological quality were scored as “yes”, “no”, or “can’t tell” in case of 
inadequate reporting. 
 
Each criterion that was scored “yes” scored 1 point, a “no” scored 0 points and if an item was 
unclear then a “?” was used to indicate this, and was treated as a missing case. Due to the 
sub-questions within criteria 5, the maximum obtainable score was 9. Accordingly, a higher 
summary quality score (>5) indicates high methodological quality, whereas a summary score 
≤5 denotes low methodological quality. The reviewers pilot tested the methodological quality 
assessment on a subset of two included articles [12,13] for agreement on a common 
interpretation of the items. The inter-rater reliability of the quality assessment was 
statistically evaluated during the pilot testing process, and 100% agreement was found 
between the two reviewers. 
 
Data extraction 
Data extraction from the selected studies was performed independently by two reviewers 
using a standardized extraction form, informed by The Cochrane Collaboration.[14] The data 
extracted included study design and methods, subject characteristics, and results data relating 
to SCD incidence. In an attempt to improve agreement in data extraction, the reviewers pilot 
tested the extraction form on a subset of two included articles.[12,13] 
 
Data analysis 
To assess the incidence of SCD in marathons, the incidence rate and 95% confidence 
intervals (CIs) were extracted from the identified reports, where the data were presented. The 
reported incidence rates were checked for consistency in calculation, to ensure the rates were 
consistently calculated and reported to ensure comparability. As differences were found in 
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some of the calculations, incidence rates and CI s were calculated for the purposes of 
comparison using The Analytic Tools for Public Health Tool for incidence rates. As it could 
not be guaranteed that the number of deaths reported in each paper were all unique deaths, 
the independence of effect sizes assumption required for a meta-analysis could not be 
assumed and therefore a meta-analysis was not conducted on the data. 
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Results 
 
Study selection  
A total of 52 records were identified through electronic database searches with an additional 
22 studies identified through the manual reference list searches. Following the removal of 
duplicate records, the total number of records screened was 59. Of the 59 records screened, 
48 were not relevant and were subsequently excluded, leaving 11 full-text articles to be 
assessed thoroughly for eligibility (Figure 1). Of the 11 potentially relevant studies, 4 were 
excluded; 2 of these studies did not evaluate SCD incidence and 2 were correspondence 
papers and did not therefore include primary data. Seven studies met the selection criteria and 
were included in this review. 
 
*Figure 1 here* 
 
Study quality 
Table 1 shows details of the methodological quality assessment of the seven included studies. 
Out of a maximum score of 9, the range of quality scores was between 3 and 7 with a mean 
score of 5.66 ± 1.75. All studies except Webner et al.’s study [15] were recruited from the 
cohort in an acceptable way – the retrospective design adopted in Webner et al.’s study may 
have led to recall bias. Webner et al. [12] and Kim et al. [13] did not report exposure 
adequately. For example, it is difficult to be sure that all race registrants actually competed in 
the event. All seven studies failed to identify all important confounding factors and therefore 
did not take this into account in their design or analysis. For example, they did not consider 
lifestyle factors like diet. Four of the seven studies were found to report trustworthy results 
when considering the design and methods adopted.[11] This was unclear in one study due to 
inadequate reporting while the results of two of studies were found to be unreliable due to the 
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methodologies used. All studies results could be applied to the population of marathon 
runners, despite variation in incidence rates across the studies. Overall, five studies were 
found to be of high methodological quality (71%), whereas two were found to be of low 
methodological quality (29%). 
 
*Table 1 here* 
 
Demographic data 
As shown in Table 1 the studies included spanned a 34-year period, ranging from 1976 to 
2010. Of the seven papers included in this review, six of the studies were conducted in the 
USA and one in the UK. The number of marathons included in the analyses in the papers 
ranged from 2 to 6 341 and included between 215,413 and 3,949,000 race 
registrants/finishers. One of the included studies [13] included race registrants in their sample 
and not competitors which may lead to an overestimation in the number of “runners”. 
 
Incidence of SCDs and demographic information on the deceased 
The number of deaths ranged from 4 to 28, which yielded incidence rates ranging between 
0.6 and 1.9 per 100,000, see Table 2. Where presented in the papers, we also documented the 
demographic information on the deceased, also presented in Table 2. The proportion of those 
suffering SCD who were male ranged from 57.1% to 100% and the mean age reported in the 
papers ranged from 37 to 48. Two of the papers provided the age range of the deceased, the 
youngest age reported was 19 and the oldest 68. 
 
*Table 2 here* 
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Discussion 
 
This study demonstrates the usefulness of a systematic review to “identify, appraise and 
synthesize all the empirical evidence that meets pre-specified eligibility criteria to answer 
a given research question”.[9] A systematic review is more rigorous than a standard literature 
review which Rousseau et al. [18] state are “often position papers, cherry-picking studies to 
advocate a point of view”. Given the importance of understanding the phenomenon of SCD 
in marathons, it is recommended that a systematic review of the literature is conducted every 
5 years. 
 
While a systematic review has been conducted on troponin elevation in marathon runners 
[19] to the best of the authors’ knowledge, this is the first systematic review to assess the 
incidence of SCD in marathons. A finding of this review is that a very small number of 
participants died suddenly during or immediately after running a marathon. 
 
The wide-ranging estimates of SCD in marathons published in the studies highlight the 
uncertainty surrounding the actual incidence of SCD in marathons. Discrepancies between 
the estimates of SCD may reflect the inconsistencies in the methodological approaches 
adopted and the quality of the studies. These issues are addressed in more detail later in this 
discussion.  
 
While the included studies reported more men than women dying from SCD in marathons, 
care should be taken not to ignore the risk to women. If the demographics of participants 
change over time with more women taking part in marathons then the profile of those at risk 
may change. The included studies looked back to a time when more men than women ran 
marathons and in the future this might change. 
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The age distribution of marathon runners is wide ranging. However, SCD in marathon 
runners is most prevalent in those between 30 and 50 years of age. Roberts, Roberts and 
Lunos [15] report that the marathon population is ageing. They found that in 1982 only 25% 
of male marathon runners and 15% of female marathon runners were over 40 years of age 
compared to 45% and 29% in 2009. These findings suggest two things. First, that there are 
greater numbers of people in the “higher risk” age group running marathons now than in the 
past. Second, that as over time the demographic profile of those participating in marathons 
has changed care must be taken when comparing data taken from marathons in the past with 
current events. The studies reported here did not control for age and gender. Future studies 
should do so.  
 
While the systematic review used the best available evidence, the methods used in the 
included studies demonstrate there is no standardized methodology for collecting data on 
SCD in marathons. Specifically, this review raises four concerns over (1) collating reports of 
SCD in marathons; (2) time of death in relation to the marathon; (3) the use of registrants 
rather than runners in the estimates of sample size; and (4 ) limited detail on runners exercise 
history. These four concerns all threaten the reliability and interpretation of any estimate of 
SCD incidence rates in marathons.  
 
While the systematic review used the best available evidence, the methods used in the 
included studies demonstrate there is no standardized methodology for collecting data on 
SCD in marathons. Specifically, this review raises four concerns over (1) collating reports of 
SCD in marathons; (2) time of death in relation to the marathon; (3) the use of registrants 
rather than runners in the estimates of sample size; and (4) limited detail on runners exercise 
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history. These four concerns all threaten the reliability and interpretation of any estimate of 
SCD incidence rates in marathons. 
 
As we argue that systematic reviews are an important method to amalgamate the findings 
from different studies, researchers should adopt procedures that enable the accurate collating 
of reports on SCD in marathons. When systematically reviewing the papers it was impossible 
to identify whether the deaths reported were unique incidences of SCD or whether there was 
considerable overlap between studies. For example, the Maron et al. [17] paper drew upon 
data from both the Marine Corps and Twin Cities marathons from 1976 to 1994; in addition, 
Roberts, Roberts, and Lunos [15] also drew upon the same marathons but from 1982 to 2009. 
Therefore, we are assuming that there will be some repeated reporting of incidence rates 
across these two papers. For this reason, a mean incidence rate was not calculated, as this 
would lead to inflation in the incidence rate which would exaggerate the risk. 
 
There is a fundamental methodological inconsistency within the literature on the definition of 
what constitutes a marathon -linked SCD . Matthews et al. [16] included deaths that occurred 
up to 24 hours post-race, whereas Kim et al. [13] included only those occurring within 1 hour 
of race completion. We do not feel qualified to determine what the time of death in relation to 
the marathon should be to be categorized as an SCD but encourage researchers in this area to 
reach on consensus on this point. 
 
Kim and colleagues [13] included all race registrants in their sample rather than race 
finishers. It has been reported that there can be substantial differences in the number of 
people who register and those who finish or participate in a marathon. The 2003 Chicago 
Marathon recorded 40,000 race registrants yet only 33,000 finishers. [20] The use of race 
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registrants and retrospective design in Kim et al. [13] may provide an explanation for the 
lower incidence rate reported as many of the race registrants may not have participated on 
race-day. 
 
A better understanding of SCD in marathons could be achieved if researchers included more 
detail on the athletic and medical history of the deceased. For example, were they elite 
athlete, performance runners, or recreational joggers?  
 
The lack of a central register for the reporting and recording of SCD in marathons is limiting 
the quality of research in this area. For example, all studies except Maron et al. [17] did not 
publish complete clinical data on all cases of SCD. A recommendation following this review 
is that a reporting register be set up to ensure complete and thorough reporting of all SCDs 
and SCAs in long-distance running events. Consequently, future research in this area could 
be conducted through accessing and utilizing a valid and reliable data source. Following this, 
more dependable research investigating the incidence of SCD in marathons could be 
conducted. 
 
It was not the aim of this research to explore the causes of SCD in marathons, or means of 
preventing SCD, as other research has begun to address these issues. Siegel [21, p. 3] has 
recently concluded that “a prudent strategy for susceptible runners would be to take prerace 
low-dose aspirin on approval by their physician”. The Journal Circulation has published 
articles and letters on the theme “Can Intensive Exercise Harm the Heart?” which are making 
a contribution to the issues raised in this review.[22] 
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Conclusions 
 
The studies included in this systematic review reported that a very small number of 
participants died suddenly during or immediately after running a marathon. The actual 
estimates ranged widely across the studies. More men are reported to have died than women 
and SCD in marathon runners is most prevalent in those aged between 30 and 50. 
 
Four methodological issues were identified which if addressed could improve research in this 
area. It is recommended that that a reporting register be set up to ensure complete and 
thorough reporting of all SCDs and SCAs in long-distance running events. 
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Figure 1. PRISMA (2009) Flow Diagram [10] 
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Table 1. Study Characteristics 
Publication Method of Estimation 
Quality 
Rating
1
 
Cou
ntry 
Year
s 
Sampl
e Size 
Number of 
Marathons 
Number 
of Deaths 
Matthews et al 
(2012) 
Racing and news databases, direct contact with race 
directors 
7 
US
A 
2000-
2009 
3,718,
336 
3,184 unique 
marathons (overall 
number of 6,341 
races) 
28 
Redelmeier & 
Greenwald (2007) 
Local newspapers, contact with race directors and 
local news media 
7 
US
A 
1975-
2004 
3,292,
268 
Screened 328 and 
selected a random 
sample of 26 
26 
Roberts, Roberts 
& Lunos (2015) 
Race records, personal communication and 
newspaper accounts. 
7 
US
A 
1982-
2009 
548,09
2 
2 7 
Maron et al 
(1996) 
Medical records, athletic history and interviews 7 
US
A 
1976-
1994 
215,41
3 
2 4 
Pedoe (2007) 
Data from St John Ambulance Brigade, hospitals 
receiving casualties and contact with coroner, 
autopsy attendance and postmortem 
6 UK 
1981-
2006 
650,00
0 
26 London 
Marathons 
8 
Kim et al (2012)
2
 Interviews, medical records and postmortem data 4 
US
A 
2000-
2010 
3,949,
000 
N/R 23 
Webner et al 
(2012) 
Web-based survey sent to marathon directors 3 
US
A 
1976-
2009 
1,710,
052 
83
4
 10 
1
 Maximal obtainable score = 9 
2 
The sample size reported in Kim et al. [20] relates to race registrants and not finishers as reported in the other included studies.  
3
 Kim et al. [20] did not report the precise number of SCDs in marathons, although incidence of cardiac arrest resulting in death in marathon 
runners was reported. Therefore, n=25 was calculated based on the sample size and incidence/100,000 reported.  
4
 83 marathon directors returned the survey, therefore we are assuming that the marathon directors were each reporting on a different marathon 
Abbreviation: N/R = Not reported  
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Table 2: Sudden cardiac deaths, incidence rates and demographic information on deceased 
Publication 
Number 
of 
Deaths 
Age of Deceased 
Sex 
Reported in the paper 
Calculated for the purposes of this 
study 
Range 
Mean age 
of deceased 
Median % Incidence 
Lower CI 
95% 
Upper CI 
95% 
Incidence 
Lower 
CI 95% 
Upper CI 
95% 
Webner et al 
(2012) 
10 N/R N/R N/R N/R N/R 0.58 N/R N/R 0.6 0.4 0.9 
Kim et al (2012) 25 N/R 33.9 N/R N/R 
19 
(83%) 
male 
6 (24%) 
female 
0.63 0.41 0.93 0.6 0.4 0.9 
Matthews et al 
(2012) 
28 22-68 N/R 41.5 
50% 
deaths 
(n=14) 
occurred 
in those 
under 45 
22 
(78.6) 
men 
6 (21.4)  
women 
0.75 0.38 1.13 0.8 0.5 1.1 
Redelmeier & 
Greenwald 
(2007) 
26 N/R 41 N/R N/R 
21 
(81%) 
men 
5 (19%) 
women 
0.8 0.5 1.1 0.8 0.5 1.2 
Pedoe (2007) 8 N/R 48 N/R N/R 
100% 
(n=8)  
male 
1.25 N/R N/R 1.2 0.5 2.4 
Roberts, Roberts 
& Lunos (2013) 
7 N/R NR N/R N/R 
4 (57.1) 
men & 3 
(42.9) 
women 
1.3 N/R N/R 1.3 0.5 2.6 
Maron et al 
(1996) 
4 19-58 37 N/R N/R 
3 (75%) 
men & 1 
(25%) 
woman 
N/R N/R N/R 1.9 0.5 4.8 
Abbreviation: N/R = Not reported  
21 
 
 
